Kuros Biosciences AG Stock Swiss Exchange
Stocks
CH0011025217
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 08-14 | Kuros Biosciences AG, H1 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Kuros Biosciences AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 849M 1.05B 905M 773M 1.45B 100B 1.47B 9.95B 3.9B 50.21B 3.94B 3.85B 167B | P/E 2026 * |
104x | P/E 2027 * | 44.5x |
|---|---|---|---|---|---|
| Enterprise Value | 838M 1.04B 894M 764M 1.44B 98.96B 1.46B 9.83B 3.85B 49.58B 3.89B 3.8B 165B | EV / Sales 2026 * |
5.03x | EV / Sales 2027 * | 3.61x |
| Free-Float |
71.26% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kuros Biosciences AG
| Manager | Title | Age | Since |
|---|---|---|---|
Christopher Fair
CEO | Chief Executive Officer | 56 | 2023-10-11 |
Joost de Bruijn
CEO | Chief Executive Officer | 60 | 2017-12-03 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 2023-02-16 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2018-06-13 | |
Joost de Bruijn
BRD | Director/Board Member | 60 | 2018-06-13 |
Oliver Walker
BRD | Director/Board Member | 57 | 2018-06-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.80% | +3.44% | +70.64% | +109.32% | 73.25B | |
| +0.09% | +14.29% | +49.28% | +90.77% | 61.95B | |
| -1.25% | -4.47% | -0.50% | +482.79% | 28.02B | |
| +5.24% | +5.65% | +56.71% | +21.30% | 24.15B | |
| +0.65% | -0.81% | -18.22% | -16.60% | 23.01B | |
| -6.00% | +6.02% | +244.39% | +430.80% | 18.35B | |
| +0.88% | +6.67% | +41.03% | -13.40% | 19.46B | |
| +3.83% | +2.65% | +21.42% | +557.58% | 15.92B | |
| +1.40% | +3.00% | +40.02% | +150.57% | 12.96B | |
| Average | +1.08% | +1.06% | +56.09% | +201.46% | 30.79B | |
| Weighted average by Cap. | +1.63% | +3.14% | +55.24% | +165.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 167M 206M 178M 152M 285M 19.67B 289M 1.95B 765M 9.85B 772M 756M 32.78B | 224M 276M 238M 204M 383M 26.4B 388M 2.62B 1.03B 13.22B 1.04B 1.01B 43.99B |
| Net income | 9.32M 11.51M 9.94M 8.49M 15.96M 1.1B 16.19M 109M 42.82M 551M 43.21M 42.27M 1.83B | 21.65M 26.73M 23.08M 19.72M 37.08M 2.56B 37.59M 254M 99.46M 1.28B 100M 98.19M 4.26B |
| Net Debt | -10.7M -13.21M -11.4M -9.74M -18.32M -1.26B -18.57M -125M -49.13M -633M -49.58M -48.51M -2.1B | -41.26M -50.94M -43.98M -37.58M -70.66M -4.87B -71.63M -484M -190M -2.44B -191M -187M -8.12B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
